Pactiv Evergreen Inc. Common stock
PTVE
PTVE was delisted on the 31st of March, 2025.
0 hedge funds and large institutions have $0 invested in Pactiv Evergreen Inc. Common stock in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 162 closing their positions.
100% less funds holding
Funds holding: 163 → 0 (-163)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $785M → $0 (-$785M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 162
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$66.5M |
| 2 |
BlackRock
New York
|
-$56.2M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$55.6M |
| 4 |
TAL
TIG Advisors LLC
New York
|
-$50.6M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$37.9M |
PTVE Hedge Fund Activity: Q2 2025 in Review
0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q2 2025, worth a combined $0 — down 100% from $785M a quarter earlier.
Sellers outnumbered buyers: 162 funds closed out of PTVE and 0 opened new positions — a net loss of 162 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $66.5M sold.
- 0 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q2 2025, down from 163 in Q1 2025.
- Funds reported $0 of Pactiv Evergreen Inc. Common stock stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new Pactiv Evergreen Inc. Common stock positions in Q2 2025 and 162 closed out, a net change of -162 holders.
- The largest Pactiv Evergreen Inc. Common stock seller in Q2 2025 was Vanguard Group, an estimated $66.5M sold.
Based on aggregated 13F filings for Q2 2025.